PADI4 and systemic lupus erythematosus: In further support of this result, pharmacological inhibition of PAD did not improve disease in the Fas/lpr model of lupus, anti-glomerular basement membrane antibody-induced model of proliferative nephritis, and human-serum-transfer model of SLE (54).